Tylenol Extra Strength Capletacetaminophen

According to the FDA label: Uses temporarily relieves minor aches and pains due to: headache the common cold backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever

265,864 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Tylenol Extra Strength Caplet in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Tylenol Extra Strength Caplet adverse event reports by reporter sex
SexReports
Female147,245
Male86,168
Unknown522

By Age Group

View age group data as a table
Tylenol Extra Strength Caplet adverse event reports by reporter age group
Age groupReports
0-1714,237
18-3421,957
35-4933,023
50-6445,680
65-7435,061
75+35,355

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Tylenol Extra Strength Caplet. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Tylenol Extra Strength Caplet adverse event reports by reported outcome
OutcomeReports
Other Serious137,994
Hospitalization114,392
Death49,848
Non-Serious42,330
Life-Threatening21,241
Disability11,686

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Tylenol Extra Strength Caplet. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Tylenol Extra Strength Caplet adverse event reports by year
YearReports
19981
19994
20011
20022
20034
20042,586
20052,681
20063,160
20072,564
20083,866
20092,961
20103,806
20118,117
20128,132
20133,632
20144,357
20158,034
201610,675
20179,494
201811,326
201914,251
202020,693
202120,758
202227,992
202329,155
202430,247
202529,938
2026 (partial)7,427

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Tylenol Extra Strength Caplet

In FDA adverse event reports that mention Tylenol Extra Strength Caplet, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026